Copyright Reports & Markets. All rights reserved.

Global Pulmonary Alveolar Proteinosis (PAP) Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pulmonary Alveolar Proteinosis (PAP) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Plasmapheresis
      • 1.4.3 Lung transplant
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Pulmonary Alveolar Proteinosis (PAP) Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgical Centers
      • 1.5.4 Diagnostic Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pulmonary Alveolar Proteinosis (PAP) Market Size
    • 2.2 Pulmonary Alveolar Proteinosis (PAP) Growth Trends by Regions
      • 2.2.1 Pulmonary Alveolar Proteinosis (PAP) Market Size by Regions (2014-2025)
      • 2.2.2 Pulmonary Alveolar Proteinosis (PAP) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Pulmonary Alveolar Proteinosis (PAP) Market Size by Manufacturers
      • 3.1.1 Global Pulmonary Alveolar Proteinosis (PAP) Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Pulmonary Alveolar Proteinosis (PAP) Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Pulmonary Alveolar Proteinosis (PAP) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pulmonary Alveolar Proteinosis (PAP) Key Players Head office and Area Served
    • 3.3 Key Players Pulmonary Alveolar Proteinosis (PAP) Product/Solution/Service
    • 3.4 Date of Enter into Pulmonary Alveolar Proteinosis (PAP) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Type (2014-2019)
    • 4.2 Global Pulmonary Alveolar Proteinosis (PAP) Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
    • 5.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in United States
    • 5.3 United States Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
    • 5.4 United States Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

    6 Europe

    • 6.1 Europe Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
    • 6.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in Europe
    • 6.3 Europe Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
    • 6.4 Europe Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

    7 China

    • 7.1 China Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
    • 7.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in China
    • 7.3 China Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
    • 7.4 China Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

    8 Japan

    • 8.1 Japan Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
    • 8.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in Japan
    • 8.3 Japan Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
    • 8.4 Japan Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
    • 9.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in Southeast Asia
    • 9.3 Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
    • 9.4 Southeast Asia Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

    10 India

    • 10.1 India Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
    • 10.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in India
    • 10.3 India Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
    • 10.4 India Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Pulmonary Alveolar Proteinosis (PAP) Market Size (2014-2019)
    • 11.2 Pulmonary Alveolar Proteinosis (PAP) Key Players in Central & South America
    • 11.3 Central & South America Pulmonary Alveolar Proteinosis (PAP) Market Size by Type
    • 11.4 Central & South America Pulmonary Alveolar Proteinosis (PAP) Market Size by Application

    12 International Players Profiles

    • 12.1 Savara
      • 12.1.1 Savara Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pulmonary Alveolar Proteinosis (PAP) Introduction
      • 12.1.4 Savara Revenue in Pulmonary Alveolar Proteinosis (PAP) Business (2014-2019)
      • 12.1.5 Savara Recent Development
    • 12.2 Cleveland Clinic
      • 12.2.1 Cleveland Clinic Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pulmonary Alveolar Proteinosis (PAP) Introduction
      • 12.2.4 Cleveland Clinic Revenue in Pulmonary Alveolar Proteinosis (PAP) Business (2014-2019)
      • 12.2.5 Cleveland Clinic Recent Development
    • 12.3 St. Antonius Hospital Nieuwegein
      • 12.3.1 St. Antonius Hospital Nieuwegein Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pulmonary Alveolar Proteinosis (PAP) Introduction
      • 12.3.4 St. Antonius Hospital Nieuwegein Revenue in Pulmonary Alveolar Proteinosis (PAP) Business (2014-2019)
      • 12.3.5 St. Antonius Hospital Nieuwegein Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Pulmonary alveolar proteinosis (PAP), also known as pulmonary alveolar phospholipoproteinosis, is a diffuse lung disease characterized by the accumulation of amorphous, periodic acid-Schiff (PAS)-positive lipoproteinaceous material in the distal air spaces.
      Treatment of PAP depends on the form of PAP and age of a patient with PAP and severity of the disease. WLL is a standard treatment for PAP and the only treatment which has shown improved symptoms and oxygenation in patients. Another treatment of PAP includes using recombinant granulocyte colony stimulating factor (GM-CSF) which is given by nose or with a subcutaneous injection which is not approved yet.
      In 2018, the global Pulmonary Alveolar Proteinosis (PAP) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Pulmonary Alveolar Proteinosis (PAP) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pulmonary Alveolar Proteinosis (PAP) development in United States, Europe and China.

      The key players covered in this study
      Savara
      Cleveland Clinic
      St. Antonius Hospital Nieuwegein
      ...

      Market segment by Type, the product can be split into
      Plasmapheresis
      Lung transplant
      Others

      Market segment by Application, split into
      Hospitals
      Ambulatory Surgical Centers
      Diagnostic Centers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Pulmonary Alveolar Proteinosis (PAP) status, future forecast, growth opportunity, key market and key players.
      To present the Pulmonary Alveolar Proteinosis (PAP) development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Pulmonary Alveolar Proteinosis (PAP) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now